Concepedia

Alexandre Wicky

AW

Statistics

Publications

10

Citations

675

H-Index

10

Active since

2019

Affiliations

University of Lausanne(Current)

The University of Sydney

Melanoma Institute Australia

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Assistance Publique – Hôpitaux de Paris

Alexandre Wicky is an author at University of Lausanne specializing in oncology, immunotherapy, and cancer immunotherapy.

Publications per year

2019–2024

10

Publications

10

Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation

Jaikumar Duraiswamy, Riccardo Turrini, Aspram Minasyan et al. · Cancer Cell · 2021 · 194 citations · Full text

Life Sciences, Immunology, Oncology +17

Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy

Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab et al. · European Journal of Cancer · 2021 · 186 citations · Full text

Life Sciences, Immunology, Oncology +16

Resident Kupffer cells and neutrophils drive liver toxicity in cancer immunotherapy

Marie Siwicki, Nicolas A. Gort-Freitas, Marius Messemaker et al. · Science Immunology · 2021 · 80 citations · Full text

Life Sciences, Immunology, Oncology +17

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

Prachi Bhave, Tasnia Ahmed, Serigne Lo et al. · Journal for ImmunoTherapy of Cancer · 2022 · 65 citations · Full text

Life Sciences, Oncology, Pharmacotherapy +17

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events

Alexander Coukos, Julien Vionnet, Michel Obéid et al. · Journal for ImmunoTherapy of Cancer · 2022 · 37 citations · Full text

Medicine, Immunology, Pathology +17

1–5 of 10